Cadence Bank Pfizer Inc Transaction History

Cadence Bank

$1.5 Billion
Q2 2025

A detailed history of Cadence Bank transactions in Pfizer Inc stock. As of the latest transaction made, Cadence Bank holds 289,803 shares of PFE stock, worth $7.93 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

289,803

Previous 259,171 11.82%

Holding current value

$7.93 Million

Previous $6.57 Million 6.96%

% of portfolio

0.47%

Previous 0.48%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$21.59 - $24.84 $661,344 - $760,898	30,632 Added 11.82%	289,803 $7.02 Million
Q1 2025 May 14, 2025	BUY	$25.01 - $27.13 $7,252 - $7,867	290 Added 0.11%	259,171 $6.57 Million
Q4 2024 Feb 13, 2025	SELL	$24.8 - $30.19 $1.76 Million - $2.14 Million	-70,812 Reduced 21.48%	258,881 $6.87 Million
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $1.51 Million - $1.71 Million	54,490 Added 19.8%	329,693 $9.54 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $128,295 - $150,338	5,079 Added 1.88%	275,203 $7.7 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $489,087 - $561,629	-18,891 Reduced 6.54%	270,124 $7.5 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $5.31 Million - $6.89 Million	203,084 Added 236.33%	289,015 $8.32 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $217,955 - $254,767	-6,792 Reduced 7.33%	85,931 $2.85 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $89,938 - $104,057	-2,490 Reduced 2.62%	92,723 $3.4 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $101,744 - $132,456	2,583 Added 2.79%	95,213 $3.88 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $23,296 - $30,411	-558 Reduced 0.6%	92,630 $4.75 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $3.3 Million - $4.03 Million	75,415 Added 424.32%	93,188 $4.08 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $43,412 - $51,473	-933 Reduced 4.99%	17,773 $932,000
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $37,972 - $47,052	-830 Reduced 4.25%	18,706 $968,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $91,317 - $135,362	-2,210 Reduced 10.16%	19,536 $1.15 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $40,427 - $51,932	-1,030 Reduced 4.52%	21,746 $935,000
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $11,850 - $13,424	330 Added 1.47%	22,776 $892,000
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $5.14 Million - $5.8 Million	-153,514 Reduced 87.24%	22,446 $813,000
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $591,749 - $752,460	17,680 Added 11.17%	175,960 $6.48 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $124,968 - $146,616	-3,936 Reduced 2.43%	158,280 $5.81 Million
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $52,408 - $63,579	1,740 Added 1.08%	162,216 $5.3 Million
Q1 2020 Apr 30, 2020	BUY	$27.03 - $38.62 $975,053 - $1.39 Million	36,073 Added 29.0%	160,476 $5.24 Million
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $357,577 - $405,804	10,862 Added 9.57%	124,403 $4.87 Million
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $198,773 - $257,751	6,118 Added 5.7%	113,541 $4.08 Million
Q2 2019 Jul 30, 2019	BUY	$36.98 - $41.52 $256,123 - $287,567	6,926 Added 6.89%	107,423 $4.65 Million
Q1 2019 May 02, 2019	BUY	$37.5 - $41.2 $79,350 - $87,179	2,116 Added 2.15%	100,497 $4.27 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $321,070 - $366,055	8,346 Added 9.27%	98,381 $4.3 Million
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $56,703 - $68,777	1,645 Added 1.86%	90,035 $3.97 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $50,921 - $54,287	1,544 Added 1.78%	88,390 $3.21 Million
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $70,265 - $81,518	2,202 Added 2.6%	86,846 $3.08 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $2.82 Million - $2.99 Million	84,644	84,644 $0

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.

Account